Harrow, Inc. (HROW)
26.04
-2.71
(-9.43%)
USD |
NASDAQ |
Nov 05, 16:00
26.20
+0.16
(+0.61%)
After-Hours: 04:29
Harrow SG&A Expense (TTM) : 175.69M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 175.69M |
| March 31, 2026 | 155.63M |
| December 31, 2025 | 152.91M |
| September 30, 2025 | 144.39M |
| June 30, 2025 | 142.18M |
| March 31, 2025 | 140.76M |
| December 31, 2024 | 129.06M |
| September 30, 2024 | 120.49M |
| June 30, 2024 | 107.88M |
| March 31, 2024 | 96.02M |
| December 31, 2023 | 83.09M |
| September 30, 2023 | 72.12M |
| June 30, 2023 | 66.50M |
| March 31, 2023 | 60.73M |
| December 31, 2022 | 58.24M |
| September 30, 2022 | 55.68M |
| June 30, 2022 | 51.61M |
| March 31, 2022 | 46.55M |
| December 31, 2021 | 41.32M |
| September 30, 2021 | 36.08M |
| June 30, 2021 | 33.16M |
| March 31, 2021 | 31.00M |
| December 31, 2020 | 31.25M |
| September 30, 2020 | 31.50M |
| June 30, 2020 | 31.67M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.96M |
| December 31, 2019 | 33.09M |
| September 30, 2019 | 34.41M |
| June 30, 2019 | 32.77M |
| March 31, 2019 | 31.30M |
| December 31, 2018 | 29.24M |
| September 30, 2018 | 26.17M |
| June 30, 2018 | 24.99M |
| March 31, 2018 | 24.70M |
| December 31, 2017 | 25.02M |
| September 30, 2017 | 24.71M |
| June 30, 2017 | 25.74M |
| March 31, 2017 | 25.92M |
| December 31, 2016 | 24.95M |
| September 30, 2016 | 25.54M |
| June 30, 2016 | 23.64M |
| March 31, 2016 | 21.35M |
| December 31, 2015 | 19.00M |
| September 30, 2015 | 15.63M |
| June 30, 2015 | 13.31M |
| March 31, 2015 | 11.69M |
| December 31, 2014 | 10.48M |
| September 30, 2014 | 9.507M |
| June 30, 2014 | 8.540M |
| March 31, 2014 | 7.338M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Viatris, Inc. | 3.094B |
| 60 Degrees Pharmaceuticals, Inc. | 6.600M |
| ANI Pharmaceuticals, Inc. | 324.76M |
| Corcept Therapeutics, Inc. | 432.49M |
| Veru, Inc. | 16.05M |